Virtu KCG Holdings’s China Pharma Holdings CPHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
$8K Buy
+65
New +$7.35K ﹤0.01% 2788
2017
Q1
Sell
-55
Closed -$7K 3198
2016
Q4
$7K Buy
+55
New +$5.85K ﹤0.01% 3310
2016
Q3
Sell
-74
Closed -$9K 3105
2016
Q2
$9K Buy
+74
New +$8.31K ﹤0.01% 2853
2016
Q1
Sell
-40
Closed -$3K 2906
2015
Q4
$3K Buy
40
+17
+74% +$1.65K ﹤0.01% 3421
2015
Q3
$2K Sell
23
-20
-47% -$2.42K ﹤0.01% 3272
2015
Q2
$8K Buy
+43
New +$7.39K ﹤0.01% 3241
2015
Q1
Sell
-40
Closed -$6K 3239
2014
Q4
$6K Buy
+40
New +$5.88K ﹤0.01% 3671
2014
Q2
Sell
-28
Closed -$7K 3697
2014
Q1
$7K Buy
28
+4
+17% +$1.1K ﹤0.01% 3464
2013
Q4
$4K Sell
24
-24
-50% -$4.04K ﹤0.01% 3750
2013
Q3
$7K Buy
+48
New +$5.55K ﹤0.01% 3650

Other funds holding CPHI

Virtu KCG Holdings's CPHI Position: Q2 2017 in Review

Virtu KCG Holdings opened a new position in China Pharma Holdings (CPHI) in Q2 2017: 65 shares worth $8K. The stake represents ﹤0.01% of the portfolio and ranks #2788 among its holdings. This is a return to the name: Virtu KCG Holdings previously reported a position in CPHI as recently as Q4 2016.

Virtu KCG Holdings first reported a position in CPHI in Q3 2013 and has held it in 10 quarters since. The position peaked at $9K in Q2 2016. 9 funds tracked by Wall St. Rank hold CPHI as of Q2 2017.

  • Virtu KCG Holdings held 65 shares of China Pharma Holdings worth $8K as of Q2 2017.
  • China Pharma Holdings was a new Virtu KCG Holdings position in Q2 2017.
  • China Pharma Holdings made up ﹤0.01% of Virtu KCG Holdings's portfolio in Q2 2017, its #2788 holding.
  • Virtu KCG Holdings first reported a position in China Pharma Holdings in Q3 2013 and has held it in 10 quarters since.
  • Virtu KCG Holdings's China Pharma Holdings position peaked at $9K in Q2 2016.
  • 9 funds tracked by Wall St. Rank held China Pharma Holdings as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.